| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2008.20.3497 |
| P698 | PubMed publication ID | 19652073 |
| P50 | author | David G. Bostwick | Q119000792 |
| P2093 | author name string | Gary Onik | |
| Matthew Miessau | |||
| P433 | issue | 26 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 4321-4326 | |
| P577 | publication date | 2009-08-03 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management | |
| P478 | volume | 27 |
| Q42836179 | 3D versus 2D Systematic Transrectal Ultrasound-Guided Prostate Biopsy: Higher Cancer Detection Rate in Clinical Practice |
| Q37981828 | A biomedical engineering approach to mitigate the errors of prostate biopsy |
| Q37787087 | Benchmarks for success in focal therapy of prostate cancer: cure or control? |
| Q35550202 | Beyond diagnosis: evolving prostate biopsy in the era of focal therapy |
| Q60685252 | Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches |
| Q43196725 | Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens |
| Q40029512 | Comparison of transperineal mapping biopsy results with whole-mount radical prostatectomy pathology in patients with localized prostate cancer. |
| Q89630679 | Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities |
| Q50014548 | Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient |
| Q35738511 | Documenting the location of prostate biopsies with image fusion |
| Q50138465 | Focal Ablation of Early-Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome |
| Q53100573 | Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy. |
| Q38139392 | Focal low-dose rate brachytherapy for the treatment of prostate cancer. |
| Q45937049 | Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study. |
| Q35220196 | Focal therapy for prostate cancer - where are we in 2011? |
| Q35827748 | Focal therapy for prostate cancer: The current status |
| Q33702259 | Focal therapy for prostate cancer: rationale and treatment opportunities |
| Q35944856 | Focal therapy in the management of prostate cancer: an emerging approach for localized prostate cancer |
| Q50239157 | Focal therapy of prostate cancer |
| Q34337324 | Focal therapy of prostate cancer: energies and procedures. |
| Q34148722 | Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria |
| Q37043970 | Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol |
| Q60910241 | Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy |
| Q26820469 | Histological outcomes after focal high-intensity focused ultrasound and cryotherapy |
| Q63966590 | MRT-navigierte stereotaktische Prostatabiopsie |
| Q35354750 | Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging |
| Q39446420 | Multi-parametric MRI imaging of the prostate-implications for focal therapy |
| Q48123071 | Optimal prostate biopsy regimen |
| Q36520508 | Overdiagnosis of prostate cancer |
| Q35700730 | PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer |
| Q63966592 | PSA density lower cutoff value as a tool to exclude pathologic upstaging in initially diagnosed unilateral prostate cancer: impact on hemiablative focal therapy |
| Q40612354 | Parameters predicting postoperative unilateral disease in patients with unilateral prostate cancer in diagnostic biopsy: a rationale for selecting hemiablative focal therapy candidates |
| Q40541815 | Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies |
| Q85776030 | Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance |
| Q30315859 | Prostate biopsy: Procedure in the clinical routine |
| Q37609671 | Prostate cancer screening and the management of clinically localized disease |
| Q64115030 | Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments |
| Q46828040 | Prostate cancer: improvements in risk stratification of prostate cancer |
| Q50244924 | Prostate focused ultrasound focal therapy--imaging for the future |
| Q43234917 | Prostate needle biopsy quality in reduction by dutasteride of prostate cancer events study: worldwide comparison of improvement with investigator training and centralized laboratory processing |
| Q41867844 | Radical prostatectomy specimens - a voice against focal therapy |
| Q39827538 | Recent advances in focal therapy of prostate and kidney cancer |
| Q37935525 | Robotic prostate biopsy and its relevance to focal therapy of prostate cancer |
| Q37937200 | Robotic transperineal prostate biopsy: pilot clinical study |
| Q40875442 | Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers |
| Q45046063 | Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy |
| Q26773645 | The current and future role of magnetic resonance imaging in prostate cancer detection and management |
| Q39382734 | The importance of active surveillance, and immediate re-biopsy in low-risk prostate cancer: The largest series from Turkey |
| Q46000995 | The predictive efficacy of hypoechoic lesion in ultrasound for prostate cancer in Chinese people: five-year experience in a moderated 10-core transperineal prostate biopsy procedure. |
| Q34266167 | The role of focal therapy in the management of localised prostate cancer: a systematic review |
| Q26849794 | The role of magnetic resonance imaging in the diagnosis and management of prostate cancer |
| Q36546399 | The role of targeted focal therapy in the management of low-risk prostate cancer: update on current challenges |
| Q36928846 | Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer |
| Q38141791 | Transperineal biopsy of the prostate--is this the future? |
| Q35100748 | Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study |
| Q33610910 | Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies |
| Q37813395 | Tumor focality in prostate cancer: implications for focal therapy |
| Q93168425 | Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT) |
| Q87916420 | Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRI |
| Q36707864 | Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL. |
| Q38874201 | What Burden of Prostate Cancer Can Radiologists Rule Out on Multiparametric Magnetic Resonance Imaging? A Sensitivity Analysis Based on Varying the Target Condition in Template Prostate Mapping Biopsies |
| Q52988831 | [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer]. |
Search more.